An elderly patient with marginally unresectable rectal cancer obtained pathological complete response by the treatment with mFOLFOX6
-
Published:2017
Issue:2
Volume:25
Page:83-87
-
ISSN:1344-6835
-
Container-title:Annals of Cancer Research and Therapy
-
language:en
-
Short-container-title:Ann. Cancer Res. Therap.
Author:
Usuda Atsuko12, Yoshimatsu Kazhuhiko2, Konno Soichi12, Yagawa Hirokazu1, Maeda Hiroyuki12, Matsuoka Aya12, Usui Takebumi12, Naritaka Yoshihiko2
Affiliation:
1. Department of Surgery, Nishiarai Hospital 2. Department of Surgery, Tokyo Women’s Medical University Medical Center East
Publisher
The Japanese Society of Strategies for Cancer Research and Therapy
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference15 articles.
1. 1) Comella, P., Natale, D., Farris, A., Gambardella, A., Maiorino, L., Massidda, B., Casaretti, R., Tafuto, S., Lorusso, V., Leo, S. and Cannone, M. (2005) Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108. Cancer. 104: 282-289. 2. 2) de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., Papamichael, D., Le Bail, N., Louvet, C., Hendler, D., de Braud, F., Wilson, C., Morvan, F. and Bonetti, A. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 18: 2938-2947. 3. 3) Folprecht, G., Gruenberger, T., Bechstein, WO., Raab, HR., Lordick, F., Hartmann, JT., Lang, H., Frilling, A., Stoehlmacher, J., Weitz, J., Konopke, R., Stroszczynski, C., Liersch, T., Ockert, D., Herrmann, T., Goekkurt, E., Parisi, F. and Köhne, CH. (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 11: 38-47. DOI: 10.1016/S1470-2045(09)70330-4 4. 4) Takahashi, T., Shibata, Y., Tojima, Y., Tsuboi, K., Sakamoto, E., Kunieda, K., Matsuoka, H., Suzumura, K., Sato, M., Naganuma, T., Sakamoto, J., Morita, S. and Kondo, K. (2013) Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study. Int J Clin Oncol. 18: 335-342. DOI: 10.1007/s10147-012-0382-z 5. 5) Hasegawa, J., Nishimura, J., Mizushima, T., Miyake, Y., Kim, HM., Takemoto, H., Tamagawa, H., Noura, S., Fujii, M., Fujie, Y., Kato, T., Miwa, H., Takemasa, I., Ikeda, M., Yamamoto, H., Sekimoto, M., Nezu, R., Doki, Y. and Mori, M. (2014) Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer. Cancer Chemother Pharmacol. 73: 1079-1087. DOI: 10.1007/s00280-014-2417-9
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|